Cleveland Biolabs (CBLI) Reports Q1 Loss of $0.06/Share

Cleveland Biolabs (NASDAQ: CBLI) reported Q1 EPS of ($0.06), versus ($1.14) reported last year. Revenue for the quarter came in at $12.5 thousand, versus $607.3 thousand reported last year.

For earnings history and earnings-related data on Cleveland Biolabs (CBLI) click here.

You May Also Be Interested In

• Rivian reports record Q3 deliveries, beats estimates, shares rise
• First Watch (FWRG) PT Lowered to $15 at DA Davidson, Buy Rating Maintained
• Integra LifeSciences cuts 2026 outlook after Cincinnati flood